Methods for treating transplant rejection
AssigneeViron Therapeutics, Inc.
InventorsAlexandra Lucas, Robert Zhong, D. Grant McFadden
Life of this patent
Estimating the term…
Abstract
Compositions and methods for treating transplant rejection in a mammalian transplant recipient are provided. The method involves administering a therapeutically effective amount of Serp-1, its analogs, and biologically active fragments thereof in combination with an anti-rejection agent, such as cyclosporin, and a pharmaceutically acceptable carrier to a subject in need of such treatment. The compositions and methods are useful for treating acute and chronic allograft and xenograft transplant rejection in mammals.
Claims12
A pharmaceutical composition comprising Serp-1, Serp-1 analog or a biologically active fragment thereof, one or more anti-rejection agents and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.